Treatment of hydroxyurea-resistant/intolerant polycythemia vera: a discussion of best practicesarticle Published on 2023-03-212024-09-02 Journal: Annals of Hematology [Category] 대상포진, [키워드] Janus kinase myeloproliferative neoplasm polycythemia vera ruxolitinib [DOI] 10.1007/s00277-023-05172-y PMC 바로가기 [Article Type] article
Management of polycythemia vera: A survey of treatment patterns in ItalyOriginal Article Published on 2022-11-102024-09-04 Journal: European journal of haematology [Category] 대상포진, [키워드] management Patterns polycythemia vera survey Treatment [DOI] 10.1111/ejh.13889 PMC 바로가기 [Article Type] Original Article
Cerebral venous thrombosis and myeloproliferative neoplasms: A three-center study of 74 consecutive cases대뇌 정맥 혈전증 및 골수 증식성 신생물: 74건의 연속 사례에 대한 3개 기관 연구Multicenter Study Published on 2021-12-012022-09-11 Journal: American journal of hematology [Category] 변종, [키워드] age Aspirin association Catholic Central nervous system cerebral CLARITY clinical Clinical features Cognitive impairment conjunction COVID COVID-19 vaccinations Diagnosis essential thrombocythemia feature female gender females Florence Follow-up Frequency headache Headaches hemorrhage highlight include Intracerebral hemorrhage involved likelihood Mayo Clinic median median age myelofibrosis myeloproliferative neoplasm myeloproliferative neoplasms neurological occurred Patient patients polycythemia vera retrospective retrospective review Rome sagittal systemic anticoagulation tested therapy thrombocythemia thrombosis Transverse university vaccination venous Venous thrombosis were recorded with COVID-19 [DOI] 10.1002/ajh.26336 PMC 바로가기 [Article Type] Multicenter Study
Increased Risk of Thrombosis in Patients with Myeloproliferative Neoplasms Compared with the General Population Hospitalized with COVID-19Conference abstract Published on 2021-11-232022-10-05 Journal: Blood [Category] 유전자 메커니즘, [키워드] 95% CI Admission age analyzed anticoagulation Aspirin baseline black bleeding blueprint board Boston categorical variable caused clinical clinically CML Cohort cohort analysis Complication consecutive patient constellation continuous variable Corticosteroid COVID COVID-19 critically ill patients D-dimer database death defined diabetes Diagnosis download figure funding General population Health heart failure Hispanic Hispanic ethnicity hospital Hospital admission Hospitalized hospitalized patient hypertension ICU ICU admission identify include Increased increased risk Incyte Infection Infectious disease Inflammatory less leukemia mass Medicine multivariable analysis multivariable logistic regression myelofibrosis myeloproliferative neoplasm Myocardial infarction occurred Older outcome Patient patient population patients PCR PCR testing Philadelphia Platelet polycythemia vera polymerase chain Population positive Primary outcome prognostic readmission Remdesivir required risk risk factor Seattle Sex significantly significantly increased smoking status Society steroid stroke t-test Test tested thrombosis thrombotic complication Thrombotic complications treated Treatment Venous Thromboembolism VTE white with COVID-19 [DOI] 10.1182/blood-2021-151801 [Article Type] Conference abstract
Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia진성적혈구증가증 및 본태성 혈소판증가증에 비해 골수섬유증 환자에서 BNT162b2 백신에 대한 낮은 반응Letter to the Editor Published on 2021-07-292022-09-12 Journal: Journal of Hematology & Oncology [Category] SARS, 진단, [키워드] active treatment anti-SARS-CoV-2 anti-SARS-CoV-2 IgG BNT162b2 BNT162b2 vaccine COVID-19 essential thrombocythemia FIVE IgG titers implicated likelihood Lower mRNA vaccine myelofibrosis neoplasm Neutralizing Patient patients Ph negative myeloproliferative neoplasms Philadelphia polycythemia polycythemia vera Prospective Study reducing ruxolitinib second dose Seroprotection rate significantly lower thrombocythemia Treatment vaccine immunogenicity [DOI] 10.1186/s13045-021-01130-1 PMC 바로가기 [Article Type] Letter to the Editor
Advances in the Treatment of Polycythemia Vera: Trends in Disease Managementarticle Published on 2021-03-302024-09-02 Journal: Cureus [Category] 대상포진, [키워드] cytoreduction hydroxyurea interferon polycythemia vera ruxolitinib Treatment [DOI] 10.7759/cureus.14193 PMC 바로가기 [Article Type] article
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19Article Published on 2021-02-042022-10-04 Journal: Blood Cancer Journal [Category] MERS, 치료제, [키워드] antiplatelet Antithrombotic biological plausibility clinically competing COVID-19 COVID-19 diagnosis cumulative drugs Effect European event examined Follow-up ICU incidence Infectious diseases Mortality mortality rate multicenter multivariate model myelofibrosis Myeloproliferative disease myeloproliferative neoplasms Patient patients patients with COVID-19 phenotype Platelet Pneumonia polycythemia vera predictor Prophylaxis reached receiving recognize regimen Registered Retrospective study risk risk factor Risk factors risk of death selected significantly lower statistically significant susceptibility thrombosis transfer Univariate analysis venous venous thromboembolic Venous Thromboembolism VTE [DOI] 10.1038/s41408-021-00417-3 PMC 바로가기 [Article Type] Article
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib Research Published on 2021-01-072022-10-05 Journal: Leukemia [Category] 치료제, [키워드] affecting age Analysis association Comorbidity COVID-19 COVID-19 diagnosis COVID-19 infection COVID-19 patient death diagnosed Diagnosis died Follow-up Gender General population high risk increased risk lymphocyte counts male median Mortality mortality rate multivariable analysis myelofibrosis myeloproliferative neoplasm Patient patients patients with COVID-19 polycythemia vera propensity score matching reached Respiratory Support risk factor ruxolitinib significantly more survival survivor therapy Treatment Withdrawal [DOI] 10.1038/s41375-020-01107-y [Article Type] Research
Ruxolitinib-Associated Infections in Polycythemia Vera: Review of the Literature, Clinical Significance, and RecommendationsReview Published on 2020-10-262024-09-02 Journal: Cancers [Category] 대상포진, [키워드] Infection polycythemia vera pv ruxolitinib [DOI] 10.3390/cancers12113132 PMC 바로가기 [Article Type] Review
New Perspectives on Polycythemia Vera: From Diagnosis to TherapyReview Published on 2020-08-132024-09-02 Journal: International Journal of Molecular Sciences [Category] 대상포진, [키워드] givinostat hydroxyurea Idasanutlin interferon polycythemia vera Risk factors ruxolitinib target therapy [DOI] 10.3390/ijms21165805 PMC 바로가기 [Article Type] Review